Serum lactate and mortality during pediatric admissions: Is 2 really the magic number?
Loomba RS, Farias JS, Villarreal EG, Flores S. Serum Lactate and Mortality during Pediatric Admissions: Is 2 Really the Magic Number?. J Pediatr Intensive Care. 2022;11(2):83-90. Published 2022 Feb 18. doi:10.1055/s-0042-1743180
The primary objective of this study was to determine if serum lactate level at the time of hospital admission can predict mortality in pediatric patients. A systematic review was conducted to identify studies that assessed the utility of serum lactate at the time of admission to predict mortality in pediatric patients. The areas under the curve from the receiver operator curve analyses were utilized to determine the pooled area under the curve. Additionally, standardized mean difference was compared between those who survived to discharge and those who did not. A total of 12 studies with 2,099 patients were included. Out of these, 357 (17%) experienced mortality. The pooled area under the curve for all patients was 0.74 (0.67-0.80, < 0.01). The pooled analyses for all admissions were higher in those who experienced mortality (6.5 vs. 3.3 mmol/L) with a standardized mean difference of 2.60 (1.74-3.51, < 0.01). The pooled area under the curve for cardiac surgery patients was 0.63 (0.53-0.72, < 0.01). The levels for cardiac surgery patients were higher in those who experienced mortality (5.5 vs. 4.1 mmol/L) with a standardized mean difference of 1.80 (0.05-3.56, = 0.04). Serum lactate at the time of admission can be valuable in identifying pediatric patients at greater risk for inpatient mortality. This remained the case when only cardiac surgery patients were included.